EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Unilateral Magnetic Resonance–Guided Focused Ultrasound Lesion of the Subthalamic Nucleus in Parkinson's Disease: A Prospective Study

Laura Armengou-Garcia iD, Carlos A Sanchez-Catasus, Iciar Aviles-Olmos iD, Adolfo Jiménez-Huete iD, Genoveva Montoya-Murillo iD, Arantza Gorospe iD, Antonio Martin-Bastida iD, Lain Hermes Gonzalez-Quarante iD, Jorge Guridi, Maria C Rodriguez-Oroz iD

Movement Disorders · 2024-12 · 39 (12) · 2230-2241

DOI: 10.1002/mds.30020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders, online erschienen am 18.09.2024. Verfasst von Laura Armengou-Garcia und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Clínica Universidad de Navarra, Pamplona, Spain. Hauptthemen laut MEDLINE: Subthalamic Nucleus, Parkinson Disease. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Unilateral subthalamic nucleus (STN) ablation using magnetic resonance–guided focused ultrasound (MRgFUS) is being explored as a new treatment for asymmetric Parkinson's disease (PD).

Objectives

The aims were to study the efficacy and safety of this treatment in asymmetric PD patients and to characterize the lesions.

Methods

This prospective, single‐center, open‐label study evaluated asymmetric PD patients at 6 (n = 20) and 12 months (n = 12) after MRgFUS lesion of the STN. The primary outcome was the change in the Movement Disorders Society‐Unified Parkinson's Disease Rating Scale, Part III (MDS‐UPDRS III), score in off medication on the treated side and the adverse events (AEs) at 6‐month follow‐up. We also evaluated cognitive–neuropsychological changes, self‐assessment of clinical improvement, and the correlation of the lesion volume with the motor outcomes.

Results

On the treated side, the MDS‐UPDRS III score (mean difference = 13.8) and the scores in rigidity, bradykinesia, and tremor improved ( P < 0.001) throughout the follow‐up compared to baseline (at 6 months: rigidity mean difference = 2.8, improvement: 83.5%; bradykinesia mean difference = 6.0, improvement: 69.4%; tremor mean difference = 4.7, improvement: 91.5%). One patient had severe weakness in the treated hemibody, 1 had moderate dyskinesia, and 1 was in moderate confusional state that became mild (weakness) or completely resolved (dyskinesia and confusional state) at 6 months. The rest of the AEs were mild. We observed no clinically relevant changes in cognitive–neuropsychological tests. The percentage of ablation of the STN correlated with the improvement in the total MDS‐UPDRS III and contralateral tremor scores ( P < 0.05).

Conclusion

Unilateral MRgFUS lesion of the STN resulted in a significant motor improvement. We observed no persistent severe AEs, although mild, mostly transient AEs were frequent. © 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Subthalamic NucleusParkinson DiseaseHumansMaleFemaleMiddle AgedAgedProspective StudiesMagnetic Resonance ImagingTreatment OutcomeTremor

Stichwörter der Autor:innen

Parkinson's diseasemagnetic resonance–guided focused ultrasoundsubthalamic nucleus (STN)

Autor:innen und Institutionen

  • Department of Neurology, Clínica Universidad de Navarra, Pamplona, Spain.
  • Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Department of Neuroscience, Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.
  • Department of Neurosurgery, Clínica Universidad de Navarra, Pamplona, Spain.

ORCID-Profile: Laura Armengou-Garcia, Iciar Aviles-Olmos, Adolfo Jiménez-Huete, Genoveva Montoya-Murillo, Arantza Gorospe, Antonio Martin-Bastida, Lain Hermes Gonzalez-Quarante, Maria C Rodriguez-Oroz

Zitieren

APA

Armengou-Garcia, L., Sanchez-Catasus, C. A., Aviles-Olmos, I., Jiménez-Huete, A., Montoya-Murillo, G., Gorospe, A., Martin-Bastida, A., Gonzalez-Quarante, L. H., Guridi, J., & Rodriguez-Oroz, M. C. (2024). Unilateral Magnetic Resonance–Guided Focused Ultrasound Lesion of the Subthalamic Nucleus in Parkinson's Disease: A Prospective Study. Movement Disorders, 39(12), 2230-2241. https://doi.org/10.1002/mds.30020

Vancouver

Armengou-Garcia L, Sanchez-Catasus CA, Aviles-Olmos I, Jiménez-Huete A, Montoya-Murillo G, Gorospe A, et al. Unilateral Magnetic Resonance–Guided Focused Ultrasound Lesion of the Subthalamic Nucleus in Parkinson's Disease: A Prospective Study. Movement Disorders. 2024;39(12):2230-2241. doi:10.1002/mds.30020

BibTeX
@article{ArmengouGarcia2024,
  author = {Armengou-Garcia, Laura and Sanchez-Catasus, Carlos A and Aviles-Olmos, Iciar and Jiménez-Huete, Adolfo and Montoya-Murillo, Genoveva and Gorospe, Arantza and Martin-Bastida, Antonio and Gonzalez-Quarante, Lain Hermes and Guridi, Jorge and Rodriguez-Oroz, Maria C},
  title = {Unilateral Magnetic Resonance–Guided Focused Ultrasound Lesion of the Subthalamic Nucleus in Parkinson's Disease: A Prospective Study},
  journal = {Movement Disorders},
  year = {2024},
  volume = {39},
  number = {12},
  pages = {2230--2241},
  doi = {10.1002/mds.30020}
}
Kostenlos starten →